Sang Yun Seok | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Sang Yun Seok | Clinical Neuroscience | Best Researcher Award 

Prof. Sang Yun Seok,  Busan Bumin Hospital, South Korea.

Dr. Sangyun Seok is a highly accomplished spine surgeon and medical academic whose career spans clinical excellence, international training, and impactful research. He completed his medical education and master’s degree at Dong-A University, followed by intensive clinical training and military service. His professional career includes esteemed positions at Asan Medical Center, Eulji Medical Center, and fellowships in the USA, UK, and Japan, culminating in his current role at Busan Bumin Hospital. Dr. Seok’s primary research focus lies in cervical spine surgery and minimally invasive techniques, with numerous publications in top-tier international journals. His clinical expertise, global collaborations, and forward-looking vision continue to influence the field of spinal surgery.

Profile

Orcid

⭐ Strengths for the Award

  • Focused Research Expertise: His specialized focus on cervical spine surgery and minimally invasive spine techniques addresses high-impact areas in clinical orthopedics and neurosurgery, benefiting both patients and the broader medical community.

  • Robust Publication Record: Dr. Seok has published in top-tier journals including Neurospine, Clinical Spine Surgery, Global Spine Journal, and J Neurosurg Spine, contributing to both practical advancements and theoretical insights in spine surgery.

⚠️ Areas for Improvement

  • Grant Acquisition and Leadership Roles: There is limited information on leading major funded research projects or international consortia. Taking lead investigator roles in large-scale studies or securing competitive research grants would significantly bolster his profile.

  • Innovation and Patents: Future work could include intellectual property contributions, such as device development, patents, or clinical guidelines, to complement his strong publication base.

🎓 Early Academic Pursuits

Dr. Sangyun Seok embarked on his medical journey at Dong-A University College of Medicine in Busan, Korea, where he earned his Bachelor’s degree in Medicine between 2006 and 2012. His passion for advancing medical knowledge led him to pursue a Master’s degree in Medicine from the same institution during 2014–2016, laying a solid academic foundation in clinical and surgical sciences. His formative years were marked by diligence, academic excellence, and a clear focus on the musculoskeletal and spinal health domains.

🏥 Professional Endeavors

Following his academic achievements, Dr. Seok underwent rigorous clinical training at Dong-A University Hospital from 2012 to 2017, where he honed his clinical and surgical skills. After serving his nation through the Korean military service from 2017 to 2020, he returned to the healthcare field with renewed dedication. His professional career advanced rapidly with appointments at Asan Medical Center in Seoul, followed by a tenure as Assistant Professor at Eulji Medical Center in Daejeon (2021–2025). Dr. Seok’s career reflects a blend of clinical service, academic leadership, and global medical engagement, including fellowships in the USA, UK, and Japan. As of 2025, he continues his professional journey at Busan Bumin Hospital, further strengthening Korea’s spine surgery community.

🔬 Contributions and Research Focus

Dr. Seok’s research contributions are deeply rooted in the field of spine surgery, with a sharp focus on the cervical spine and minimally invasive surgical techniques. His academic output reflects a commitment to improving surgical outcomes and patient recovery. Among his impactful works are studies on vertebral osteotomy for cervical myelopathy, postoperative delirium after knee arthroplasty, and minimally invasive approaches in complex cervical procedures. His research has been published in reputable journals such as Neurospine, Clinical Spine Surgery, Global Spine Journal, and Journal of Neurosurgery: Spine, underlining his authority and innovation in spine surgery.

Publication


Title: Analysis of Early Post-Radiation Surgical Management of Metastatic Spinal Tumors
Author: SANGYUN SEOK, Jae Hwan Cho, Hyung Rae Lee, Jae Woo Park, Jin Hoon Park, Dong-Ho Lee, Chang Ju Hwang, Sehan Park
Year: 2025


Title: Mechanical Stability and Clinical Outcomes Following Posterior Cervical Fusion Surgery Using C3-6 Lateral Mass Screw Fixation: En Bloc Versus Regional Screw Fixation
Author: Dong-Ho Lee, SANGYUN SEOK, Woon Sang Lee, Hyung Rae Lee, Sehan Park, Chang Ju Hwang, Jae Hwan Cho
Year: 2025

🏁 Conclusion

Dr. Sangyun Seok is highly deserving of the Best Researcher Award. His trajectory is marked by deep scientific curiosity, technical mastery, and global vision. His work has already contributed meaningfully to advancing spinal surgery, and with continued research leadership, he is poised to make even greater contributions in the years ahead. Recognizing him with this award would not only honor his current accomplishments but also inspire future breakthroughs in spine medicine and academic surgery.

Mohamad-Reza Aghanoori | Neurodegenerative Disorders | Best Researcher Award

Published on by Neuroscientists

Dr. Mohamad-Reza Aghanoori | Neurodegenerative Disorders | Best Researcher Award

Dr. Mohamad-Reza Aghanoori, National Institute of Genetic Engineering and Biotechnology,  Iran.

Dr. Mohamad-Reza Aghanouri is a distinguished neuroscientist and molecular medicine expert whose academic journey spans Iran and Canada. Beginning with foundational training in genetics and human biology, he has advanced into a dynamic career focused on translational neuroscience, particularly the genetic regulation of neurodevelopmental and neurodegenerative disorders. His doctoral and postdoctoral research have contributed significant insights into insulin/IGF-1 signaling, mitochondrial function, and gene expression related to autism and diabetic neuropathy.

Profile

Google Scholar

🎓 Early Academic Pursuits

Mohamad-Reza Aghanouri embarked on his academic journey with a B.Sc. in Cellular and Molecular Biology–Genetics from Shahid Chamran University of Ahvaz, Iran, in 2009. His keen interest in the intricate mechanics of human biology led him to pursue an M.Sc. in Human Genetics at Shiraz University of Medical Sciences, where he explored non-invasive techniques for early sex determination through free fetal DNA analysis. His growing passion for neuroscience and genetics culminated in a Ph.D. from the University of Manitoba, Canada, where he studied at the Department of Pharmacology and Therapeutics and the Division of Neurodegenerative Disorders. His doctoral thesis, focused on insulin/IGF-1 regulation of mitochondrial function in diabetic neuropathy, laid a strong foundation for a dynamic career in translational neurogenetics.

🧬 Professional Endeavors in Translational Neuroscience

Dr. Aghanouri’s postdoctoral work reflects a robust engagement with translational neuroscience and molecular medicine. From 2019 to 2024, he served as a postdoctoral fellow at the Department of Medical Genetics, Cumming School of Medicine, University of Calgary, under the mentorship of Dr. Guang Yang. His research investigated translational regulation of genes implicated in brain development, especially in autism spectrum disorders and rare neurodevelopmental conditions. Prior to that, he worked with Prof. Paul Fernyhough in Winnipeg, Canada, where he examined the role of IGF-1 in ATP production in sensory neurons under diabetic stress conditions. His diverse experience also includes a pivotal R&D advisory role at Roya Bio Gene Company in Tehran, showcasing his versatility across both academic and industrial biosciences.

🔬 Contributions and Research Focus

Dr. Aghanouri’s research contributions bridge the realms of neurodevelopment, metabolism, and genetic regulation. He has delved into the complex interplay between growth factors like IGF-1 and mitochondrial dynamics, particularly in relation to diabetic neuropathy. At the University of Calgary, his postdoctoral investigations explored the molecular pathways influencing neurodevelopmental disorders, positioning his work at the intersection of genomics and neuroscience. His methodological expertise spans cellular models, gene expression analysis, and translational bioinformatics, underscoring a commitment to discovering mechanisms that translate molecular findings into therapeutic insights.

🏆 Accolades and Recognition

Over the course of his academic and research career, Dr. Aghanouri has amassed a commendable list of honors. He received the prestigious CIHR postdoctoral fellowship (CA$40,000 annually, plus research allowance), along with additional fellowships from the Alberta Children’s Hospital Research Institute and the Cumming School of Medicine. Notably, he clinched first place in the Striking Image Competition at the University of Calgary and was honored by the BoniadMelliNokhbegan Foundation for his exceptional research talent. He has also earned multiple research grants from Iranian institutions in 2023 and 2024, reflecting his cross-border research impact and trust among funding bodies.

📚 Institutional Leadership and Influence

In 2024, Dr. Aghanouri was appointed as the Head of the Library, Documentation, Scientometrics, and Publication Center at the National Institute of Genetic Engineering and Biotechnology (NIGEB) in Tehran. He also holds a faculty position in the Department of Molecular Medicine at NIGEB. These roles position him as a key academic leader in Iran’s scientific community, where he not only continues his research but also shapes institutional research strategies, publication ethics, and scientific communication infrastructures. His work contributes significantly to Iran’s national bioscience and health research priorities.

🌍 Impact and Global Engagement

With academic roots in Iran and a decade of research training in Canada, Dr. Aghanouri exemplifies international scientific collaboration. His work addresses global health concerns, such as diabetes-induced neuropathies and neurodevelopmental disorders like autism, thus resonating with both clinical and scientific audiences worldwide. Through his active participation in conferences, poster competitions, and collaborative projects, he serves as a bridge between Iranian biotechnology advancements and the international research community.

🔮 Legacy and Future Contributions

Looking ahead, Dr. Aghanouri is poised to further advance the fields of molecular neurogenetics and translational medicine. His ongoing research is expected to uncover novel genetic mechanisms underlying brain development and metabolic dysfunctions. As a faculty member and research leader, he is mentoring the next generation of Iranian scientists while enhancing the global understanding of complex neurological diseases. His integrated approach to research, policy, and education ensures that his legacy will be one of both scientific innovation and institutional transformation.

Publication

 

  • Betulin and its derivatives as novel compounds with different pharmacological effects
    S Amiri, S Dastghaib, M Ahmadi, P Mehrbod, F Khadem, H Behrouj, …
    2020

 

  • Oxidized phosphatidylcholines trigger ferroptosis in cardiomyocytes during ischemia-reperfusion injury
    A Stamenkovic, KA O’Hara, DC Nelson, TG Maddaford, AL Edel, …
    2021

 

  • Insulin-like growth factor-1 activates AMPK to augment mitochondrial function and correct neuronal metabolism in sensory neurons in type 1 diabetes
    MR Aghanoori, DR Smith, S Shariati-Ievari, A Ajisebutu, A Nguyen, …
    2019

 

  • The ER stress/UPR axis in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis
    M Aghaei, S Dastghaib, S Aftabi, MR Aghanoori, J Alizadeh, P Mokarram, …
    2020

 

  • MiRNA molecular profiles in human medical conditions: Connecting lung cancer and lung development phenomena
    MR Aghanoori, B Mirzaei, M Tavallaei
    2014

 

  • Mechanisms targeting the unfolded protein response in asthma
    S Dastghaib, PS Kumar, S Aftabi, G Damera, A Dalvand, A Sepanjnia, …
    2021

 

  • Nucleocytoplasmic transport of the RNA-binding protein CELF2 regulates neural stem cell fates
    MJ MacPherson, SL Erickson, D Kopp, P Wen, MR Aghanoori, S Kedia, …
    2021

 

  • CYP2E15B, CYP2E16, CYP2E17B, CYP2E12, and CYP2E1*3 Allele Frequencies in Iranian Populations
    GM Shahriary, H Galehdari, A Jalali, F Zanganeh, SMR Alavi, …
    2012

 

  • Insulin prevents aberrant mitochondrial phenotype in sensory neurons of type 1 diabetic rats
    MR Aghanoori, DR Smith, SR Chowdhury, MG Sabbir, NA Calcutt, …
    2017

 

  • CEBPβ regulation of endogenous IGF-1 in adult sensory neurons can be mobilized to overcome diabetes-induced deficits in bioenergetics and axonal outgrowth
    MR Aghanoori, P Agarwal, E Gauvin, RS Nagalingam, R Bonomo, …
    2022

✅ Conclusion

Dr. Aghanouri stands out as a versatile and impactful scientist whose contributions to neuroscience and genetic medicine hold promise for both understanding and treating complex neurological conditions. His career reflects a strong blend of academic excellence, international collaboration, and leadership in research development. As he continues to build bridges between Iranian and global biosciences, his future work is expected to leave a lasting legacy in molecular neuroscience and translational medicine.

 

Toru Yoshiura | Clinical Neuroscience | Neuroscience Research Excellence Award

Published on by Neuroscientists

Dr. Toru Yoshiura | Clinical Neuroscience | Neuroscience Research Excellence Award

Dr. Toru Yoshiura,  National Defense Medical College, Japan.

Dr. Toru Yoshiura, a Lieutenant Commander in the Japan Maritime Self-Defense Force (JMSDF) and a board-certified neurosurgeon, has cultivated a remarkable career blending military service, clinical excellence, and academic research. A graduate of the National Defense Medical College, he has pursued specialized training in diving medicine and neuroendoscopic surgery while serving in key clinical and field deployments, including anti-piracy missions. His research focuses on innovative neuroprotective strategies for subarachnoid hemorrhage, and he actively contributes to the education of future neurosurgeons through specialized anatomical dissection courses. Dr. Yoshiura holds multiple national certifications and is an active member of prominent neurosurgical societies, where he plays a leadership role in advancing young professionals.

Profile

Orcid

🎓 Early Academic Pursuits

Born on January 15, 1987, in Hiroshima, Japan, Dr. Toru Yoshiura began his distinguished journey in medicine with a solid academic foundation at the National Defense Medical College, where he pursued his studies from April 2005 to March 2011. During these formative years, he developed a strong inclination toward the intricate world of neurosurgery. His academic journey was not limited to conventional study; he also completed rigorous military medical training at the JMSDF Officer Candidate School in 2011 and the Diving Medical Officer’s Course in 2013. Driven by both curiosity and commitment, Dr. Yoshiura later pursued graduate studies in medicine at the same institution, where he currently investigates novel therapeutic strategies in neurosurgical conditions, particularly focusing on cerebral ischemia models.

⚓ Professional Endeavors

Dr. Yoshiura’s career seamlessly blends clinical excellence with military service. Since 2011, he has been a commissioned officer in the Japan Maritime Self-Defense Force (JMSDF), rising to the rank of Lieutenant Commander. His professional journey commenced with a clinical residency at the National Defense Medical College Hospital, followed by a tenure as a neurosurgeon at JSDF Yokosuka Hospital, where he also took part in the 17th Deployment Surface Force Counter Piracy Enforcement in 2013–2014. Subsequent assignments included advanced clinical residency, service at the JSDF Central Hospital, and another deployment during the 37th Counter Piracy Enforcement (2020–2021). Currently, he practices at the National Defense Medical College Hospital, where he brings both his clinical and research expertise to the forefront.

🧠 Contributions and Research Focus

Dr. Yoshiura has emerged as a dedicated researcher with a keen interest in neuroprotection and neurovascular recovery. His ongoing doctoral research explores the synergistic effects of hydrogen inhalation and intrathecal magnesium sulfate treatment in enhancing ischemic outcomes without suppressing cortical spreading depolarization—work that promises to revolutionize the management of subarachnoid hemorrhage (SAH). Moreover, he serves as the Course Director of the White Matter Dissection Course, a specialized program aimed at enhancing neurosurgical anatomical understanding, further showcasing his commitment to academic mentorship and the future of neurosurgical training.

🏅 Accolades and Recognition

Dr. Yoshiura’s dedication to excellence has been officially recognized through multiple prestigious medical certifications in Japan. He holds certifications from the Japanese Boards of Neurosurgery, Stroke, Neuroendovascular Therapy, and Neurotraumatology, and he is also a qualified Neuroendoscopic Surgeon. His credentials reflect a consistent track record of advanced surgical training and expertise across a spectrum of subspecialties, reinforcing his status as a versatile and trusted neurosurgeon in both military and civilian healthcare settings.

🌐 Impact and Influence

Beyond operating rooms and laboratories, Dr. Yoshiura has made meaningful contributions to the broader medical and scientific community through active engagement with multiple professional organizations. He is a core member of the Under 40 Committee of the Japanese Congress for Brain Tumor Surgery, signifying his leadership among emerging neurosurgeons. His involvement spans a wide array of societies, including the Japan Neurosurgical Society, Japanese Society on Surgery for Cerebral Stroke, and Japan Society for Neuro-Oncology, among others. This multi-society participation not only amplifies his influence but also allows him to remain at the cutting edge of developments in neurosurgical practice and policy.

🌍 Service Beyond Borders

Dr. Yoshiura’s compassion and sense of duty extend beyond his professional obligations. In 2010, he volunteered at a kindergarten in Bari, Indonesia, demonstrating his humanitarian spirit and willingness to serve communities in need. This formative experience abroad may have enriched his global outlook on medicine and underscored the human side of healthcare—a trait that continues to inform his interactions with patients and peers alike.

🚀 Legacy and Future Contributions

As a rising leader in neurosurgery within the military-medical sphere, Dr. Yoshiura’s legacy is already being defined by a synthesis of cutting-edge research, exceptional surgical practice, and dedicated mentorship. With his ongoing doctoral work poised to make significant contributions to the treatment of ischemic brain injuries, and his involvement in advanced neurosurgical education, he is set to influence both clinical practices and the next generation of neurosurgeons. His unique integration of military precision and academic rigor ensures that his future contributions will be both impactful and enduring.

Publication

  1. Title: Carotid Endarterectomy with Twisted Internal Jugular Vein Located Anterior to the Common Carotid Artery
    Authors: Arumu Endo, Terushige Toyooka, Kazuya Fujii, Satoru Takeuchi, Toru Yoshiura, Masaya Nakagawa, Yohei Otsuka, Arata Tomiyama, Kojiro Wada
    Year: 2025

 

  1. Title: Effectiveness of Keyhole Clipping of Unruptured Intracranial Aneurysms Detected by “Brain Dock” in Healthy Japanese Adults
    Authors: Toru Yoshiura, Satoru Takeuchi, Terushige Toyooka, Arata Tomiyama, Kojiro Wada, Yasuaki Nakao, Takuji Yamamoto, Kentaro Mori, toruyukiko
    Year: 2023

 

  1. Title: KLC1-ROS1 Fusion Exerts Oncogenic Properties of Glioma Cells via Specific Activation of JAK-STAT Pathway
    Authors: Takashi Fujii, Yoshiko Nakano, Daichi Hagita, Nobuyuki Onishi, Arumu Endo, Masaya Nakagawa, Toru Yoshiura, Yohei Otsuka, Satoru Takeuchi, Mario Suzuki et al.
    Year: 2023

 

  1. Title: Surgical Rescue Technique for Incomplete Burr Hole Using a Small Bone Piece and the Craniotome
    Authors: Toru Yoshiura, Kojiro Wada, Kosuke Kumagai, Satoru Takeuchi, Terushige Toyooka, Otani, Kentaro Mori
    Year: 2019

🔚 Conclusion

Dr. Yoshiura’s journey exemplifies a rare integration of surgical mastery, military discipline, and scientific innovation. His commitment to advancing the field of neurosurgery—through both cutting-edge research and hands-on mentorship—positions him as a future leader in academic and military medicine alike. With a career rooted in service, science, and skill, Dr. Yoshiura is not only shaping current practices but also building a lasting legacy for future generations of neurosurgeons in Japan and beyond.

Baoman Li | Neuroanatomy | Best Researcher Award

Published on by Neuroscientists

Prof. Baoman Li | Neuroanatomy | Best Researcher Award

Prof. Baoman Li, China Medical University,  China.

Professor Baoman Li stands at the forefront of contemporary neuroscience and pharmacology, merging deep academic knowledge with impactful translational research. From his foundational training at China Medical University to his postdoctoral work in the United States, he has consistently demonstrated excellence in exploring the physiological and molecular mechanisms of the central nervous system. Currently a Professor and Department Director, his work has revealed novel insights into cerebrospinal fluid transport, neuronal excitability regulation, and bipolar disorder modeling. These discoveries have been featured in top-tier journals such as PNAS, Cell Metabolism, and Molecular Psychiatry.

Profile

Scopus

🎓 Early Academic Pursuits

Baoman Li’s journey into the world of biomedical science began with a strong academic foundation. He pursued his Ph.D. in Medical Pharmacology at China Medical University, where he cultivated a keen interest in the intersection of neuroscience, pharmacology, and toxicology. His early research provided him with an in-depth understanding of neural mechanisms and laid the groundwork for his future innovations. Eager to expand his international experience, he furthered his postdoctoral research at the University of Rochester Medical Center (USA) from 2013 to 2014, where he deepened his expertise in neuropharmacological research.

🧪 Professional Endeavors

Currently serving as a Professor and Department Director at the Forensic Analytical Toxicology Department of China Medical University, Professor Li leads a dynamic team of researchers and scholars. His leadership has not only enhanced academic standards within the department but has also positioned it as a center of excellence in the field of neuroglial research and forensic toxicology. His multidisciplinary approach merges analytical science with neuroscience, significantly advancing our understanding of central nervous system (CNS) function and dysfunction.

🧠 Contributions and Research Focus

Professor Li’s research focuses on cutting-edge discoveries related to neural mechanisms, cerebrospinal fluid dynamics, and neuropsychiatric disorders. One of his landmark studies, published in PNAS (2024), identified ependymal cell-mediated cerebrospinal fluid transport from the CNS to peripheral organs, revealing a critical physiological communication pathway. In another pivotal contribution in Cell Metabolism (2025), he elucidated the role of the NE-FFA-Na⁺/K⁺-ATPase pathway in regulating neuronal hyperexcitability and behavioral arousal. Moreover, his groundbreaking development of a circadian disruption-induced manic mouse model for bipolar disorder research (published in Molecular Psychiatry, 2023) has provided a valuable tool for studying mood disorders and developing new therapeutic approaches.

📚 Academic Publications and Editorial Work

With an impressive academic portfolio, Professor Li has authored and edited three influential books centered on neuroglial science, expanding the literature in this specialized domain. His published works include notable titles with ISBNs: 978-7-117-34321-3, 978-3-030-77375-5, and 978-2-88963-497-2. These contributions serve as essential resources for both emerging and seasoned neuroscientists, offering detailed insights into glial biology, neurochemical interactions, and translational research.

🏅 Accolades and Recognition

Professor Li’s scholarly excellence is widely recognized, as reflected in his H-index of 34 and a total citation count of 3,530 according to Web of Science. His ability to consistently produce high-impact research has made him a respected voice in neuroscience and pharmacology. He has successfully led eight research projects funded by prestigious bodies such as the Natural Science Foundation of China and the Ministry of Education, while also currently heading two additional projects supported by the provincial science foundation.

🤝 Industry and Consultancy Impact

Beyond academic circles, Professor Li has extended his expertise into practical applications through four consultancy projects, bridging the gap between research and real-world forensic or pharmaceutical needs. His ability to translate complex neuropharmacological findings into actionable insights for the industry underscores his role as not only a theorist but also a problem-solver and innovator.

🔬 Legacy and Future Contributions

As a scientist, educator, and leader, Professor Baoman Li continues to shape the future of neuroscience and pharmacological toxicology. His ongoing research and collaborative efforts are expected to yield further breakthroughs in understanding brain-behavior relationships and disease mechanisms. With a legacy already marked by innovation and impact, his future contributions promise to enhance diagnostics, treatments, and preventive strategies for neurological and psychiatric disorders. His commitment to mentoring young scholars and editing academic literature ensures that his influence will resonate across generations of researchers to come.

Publication

  • Title: Cerebrospinal Fluid Enters Peripheral Organs by Spinal Nerves Supporting Brain–Body Volume Transmission
    Authors: Li, Baoman; Xia, Maosheng; Harkany, Tibor; Verkhratsky, Alexei N.
    Year: Not specified (likely 2024 or 2025)

 

  • Title: Anti-seizure effects of norepinephrine-induced free fatty acid release
    Authors: Li, Baoman; Sun, Qian; Ding, Fengfei; Smith, Nathan A.; Nedergaard, Maiken
    Year: 2025
    Journal: Cell Metabolism

 

  • Title: Major depressive disorder: hypothesis, mechanism, prevention and treatment
    Authors: Cui, Lulu; Li, Shu; Wang, Siman; Xia, Maosheng; Li, Baoman
    Year: Not specified (likely 2024 or 2025)
    Type: Review (Open access)

 

  • Title: The periaxonal space as a conduit for cerebrospinal fluid flow to peripheral organs
    Authors: Li, Xinyu; Wang, Siman; Zhang, Dianjun; Xia, Maosheng; Li, Baoman
    Year: 2024
    Journal: Proceedings of the National Academy of Sciences of the USA (Open access)

 

  • Title: Dexmedetomidine improves the circulatory dysfunction of the glymphatic system induced by sevoflurane through the PI3K/AKT/ΔFosB/AQP4 pathway in young mice
    Authors: Wang, Shuying; Yu, Xiaojin; Cheng, Lili; Lu, Yan; Wu, Xu
    Year: 2024
    Journal: Cell Death and Disease (Open access)

 

  • Title: Ketamine administration causes cognitive impairment by destroying the circulation function of the glymphatic system
    Authors: Wu, Xue; Wen, Gehua; Yan, Lei; Lu, Yan; Wu, Xu
    Year: 2024
    Journal: Biomedicine and Pharmacotherapy (Open access)

 

  • Title: Correction to: Ketamine Improves the Glymphatic Pathway by Reducing the Pyroptosis of Hippocampal Astrocytes in the Chronic Unpredictable Mild Stress Model
    Authors: Wen, Gehua; Zhan, Xiaoni; Xu, Xiaoming; Lu, Yan; Wu, Xu
    Year: 2024
    Journal: Molecular Neurobiology (Erratum, Open access)

 

  • Title: Ketamine Improves the Glymphatic Pathway by Reducing the Pyroptosis of Hippocampal Astrocytes in the Chronic Unpredictable Mild Stress Model
    Authors: Wen, Gehua; Zhan, Xiaoni; Xu, Xiaoming; Lu, Yan; Wu, Xu
    Year: 2024
    Journal: Molecular Neurobiology

 

  • Title: Trace metals and astrocytes physiology and pathophysiology
    Authors: Li, Baoman; Yu, Weiyang; Verkhratsky, Alexei N.
    Year: 2024
    Journal: Cell Calcium

 

Conclusion:

Dr. Baoman Li is a strong and deserving candidate for the Best Researcher Award. His innovative research, publication in high-impact journals, and interdisciplinary contributions demonstrate excellence and sustained scientific productivity. While he can enhance his visibility and further define his leadership role, his current achievements are more than sufficient to merit this prestigious recognition.

 

stefano | Clinical Neuroscience | Innovative Research Award

Published on by Neuroscientists

Dr. Stefano | Clinical Neuroscience | Innovative Research Award

Dr. Stefano, Ospedale Santa Chiara Trento, Italy.

Dr. Stefano Branzoli is a highly accomplished cardiac surgeon with decades of experience spanning Italy, Belgium, and the United States. After completing his medical studies at the University of Pavia, he advanced through elite international training, including a fellowship at the Mayo Clinic. His career has focused on surgical innovation in cardiac electrophysiology, with particular emphasis on thoracoscopic ablation for atrial fibrillation, stroke prevention, and ventricular arrhythmias. Through his roles at Santa Chiara Hospital and Universitair Ziekenhuis Brussel, he has contributed extensively to both clinical practice and academic research.

Profile

Orcid

🧬 Early Academic Pursuits


Dr. Stefano Branzoli began his journey into medicine at the prestigious University of Pavia, where he earned his degree in Medicine and Surgery between 1992 and 1998. Driven by a deep curiosity for cardiovascular science, he embarked on rigorous postgraduate training, marking the start of an extraordinary career in cardiac surgery. His academic excellence soon opened international doors, including a coveted fellowship at the Mayo Clinic in Rochester, Minnesota.

🏥 Professional Endeavors


From 1999 to 2004, Dr. Branzoli honed his clinical expertise as a resident in cardiac surgery at the University of Pavia. He became board-certified after completing the USMLE in 2000, equipping him with transatlantic qualifications. Since 2005, he has served in the Cardiac Surgery Unit at Santa Chiara Hospital in Trento, Italy, while also expanding his reach as a specialist at the Universitair Ziekenhuis Brussel in Belgium since 2019. These dual roles reflect his commitment to advancing surgical standards across borders.Contributions to Cardiac ElectrophysiologyThroughout his career, Dr. Branzoli has been instrumental in the development and refinement of procedures targeting arrhythmias. His clinical and research contributions in thoracoscopic ablation for atrial fibrillation, stroke prevention, and epicardial ablation for ventricular arrhythmias have positioned him as a leading voice in electrophysiological cardiac surgery. He has been particularly focused on minimally invasive techniques that reduce patient recovery time while enhancing procedural efficacy.

🔬 Research Focus and Innovation


Dr. Branzoli’s research portfolio reflects his dedication to solving complex cardiovascular challenges. He has led and contributed to significant projects centered on atrial fibrillation, stroke prevention strategies, and novel ablative techniques. His work bridges the gap between traditional surgical approaches and cutting-edge electrophysiological interventions, helping shape the future of cardiac care through both clinical practice and investigative science.

🏅 Accolades and Recognition


Though modest in demeanor, Dr. Branzoli’s accomplishments have earned him respect in academic and clinical circles alike. His training at the Mayo Clinic—a global epicenter for cardiac research—along with his dual appointments in Italy and Belgium, speak volumes of his international reputation. His involvement in advanced cardiac rhythm management has earned recognition from peers and institutions aiming to elevate surgical excellence.

🌍 Impact and Influence


Beyond the operating theater, Dr. Branzoli’s influence is reflected in the widespread adoption of thoracoscopic ablation techniques and his mentorship of upcoming cardiac surgeons in Europe. By integrating cross-border expertise, he has played a vital role in aligning surgical standards and promoting collaborative research between institutions in Italy, Belgium, and beyond.

🔮 Legacy and Future Contributions


As medicine evolves toward personalized, minimally invasive therapies, Dr. Branzoli stands at the forefront of surgical innovation. His work continues to inspire new pathways in arrhythmia management and stroke prevention. With a career spanning continents and a mind open to continual learning, his legacy is defined not only by lives saved but also by knowledge passed on to future generations of cardiovascular specialists.

Publication

  • Title: Patients with Gastrointestinal Bleeding and Atrial Fibrillation: Potential Ideal Target for Epicardial Appendage Occlusion
    Authors: Stefano Branzoli, Massimiliano Marini, Domenico Catanzariti, Cecilia Pravadelli, Luigi Pannone, Giovanni D’Onghia, Mauro Fantinel, Fabrizio Guarracini, Gaia Franceschini, Mirco Zadro et al.
    Year: 2025

 

  • Title: Heart Team for Left Appendage Occlusion without the Use of Antithrombotic Therapy: The Epicardial Perspective
    Authors: Stefano Branzoli, Fabrizio Guarracini, Massimiliano Marini, Giovanni D’Onghia, Domenico Catanzariti, Elettra Merola, Luciano Annicchiarico, Giulia Casagranda, Chiara Stegagno, Mauro Fantinel et al.
    Year: 2022

 

✅ Conclusion


Dr. Branzoli’s enduring commitment to advancing cardiac surgery has had a meaningful impact on patient care, research, and education. With a legacy rooted in innovation, cross-cultural collaboration, and a passion for arrhythmia management, he continues to influence the evolving field of cardiovascular medicine. His work serves as a bridge between traditional surgical methods and modern electrophysiological therapies—ensuring that the future of heart care is not only safer and more effective but also profoundly human-centered.

Che Ping Cheng | Translational Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Che Ping Cheng | Translational Neuroscience | Best Researcher Award

Prof. Che Ping Cheng, Wake Forest University School of Medicine, United States.

Dr. Che Ping Cheng, M.D., Ph.D., FAHA, is a distinguished cardiovascular physiologist and internal medicine specialist whose career has been dedicated to advancing the understanding of heart function and failure. From earning his medical degree in China to completing a Ph.D. in Physiology at Wayne State University, and later conducting pivotal postdoctoral research at Wake Forest School of Medicine, Dr. Cheng has consistently pursued excellence in science and education. His research on ventricular mechanics, volume loading, and heart failure has significantly influenced both experimental cardiology and clinical practice. Recognized as a Fellow of the American Heart Association, he is also a dedicated mentor, shaping the next generation of cardiovascular researchers through his academic leadership.

Profile

Scopus

 

🎓 Early Academic Pursuits

Dr. Che Ping Cheng’s journey into medicine and science began in Nanjing, China, where he earned his M.D. degree from Nanjing Railway Medical University in 1977. His early academic path reflected a deep interest in understanding the intricacies of human health, particularly in cardiovascular physiology. Driven by a desire to expand his knowledge and research capabilities, Dr. Cheng pursued his Ph.D. in Physiology at Wayne State University School of Medicine in Detroit, Michigan, completing his degree in 1986. Under the mentorship of Dr. Robert S. Shepard, his doctoral work focused on exploring the mechanisms of cardiovascular response to volume loading in a canine model with tricuspid valvulectomy, setting a strong foundation for his lifelong focus on heart function and disease mechanisms.

🩺 Professional Endeavors

Following his academic training, Dr. Cheng embarked on postdoctoral studies at the Bowman Gray School of Medicine (now part of Wake Forest School of Medicine), where he continued to cultivate his expertise in internal medicine and cardiovascular physiology. Between 1986 and 1988, he served as a Postdoctoral Fellow under the guidance of Dr. William C. Little. His research during this period focused on ventricular dynamics and the physiological factors affecting active ventricular filling, which would later inform his broader work on heart failure and cardiac function. Dr. Cheng has since remained at Wake Forest School of Medicine, where he is currently a distinguished member of the Section on Cardiovascular Medicine.

🧪 Contributions and Research Focus

Dr. Cheng’s career has been characterized by a deep commitment to advancing the understanding of cardiac hemodynamics, ventricular interaction, and heart failure mechanisms. His research has explored how ventricular function responds under altered physiological states, and how these responses inform disease progression and treatment strategies. His early animal model studies have provided critical insights into the interplay between structural and functional changes in the heart, especially in the context of diastolic dysfunction and volume overload conditions. Dr. Cheng has also made significant strides in translating these findings to clinical contexts, influencing how cardiologists approach diagnosis and therapy.

🏅 Accolades and Recognition

Throughout his career, Dr. Cheng has received considerable recognition for his scholarly contributions. He is a Fellow of the American Heart Association (FAHA), an honor that reflects his standing in the field of cardiovascular research and his commitment to scientific excellence. His work has earned the respect of colleagues and institutions alike, leading to numerous invitations to contribute to collaborative projects, serve on peer-review panels, and mentor future generations of cardiovascular researchers.

🌍 Impact and Influence

Dr. Cheng’s work has had a lasting impact on both experimental and clinical cardiology. By elucidating the mechanistic basis of ventricular dysfunction, he has helped shift paradigms in heart failure management, particularly in the areas of ventricular interdependence and preload responsiveness. His research findings are frequently cited in textbooks and high-impact journals, and they continue to inform guidelines for cardiac care and interventions. Through his work at Wake Forest and beyond, Dr. Cheng has played a pivotal role in bridging laboratory discoveries with bedside applications.

👨‍🏫 Legacy and Mentorship

As a respected mentor and educator, Dr. Cheng has dedicated a significant portion of his career to training medical students, residents, and postdoctoral fellows. His mentorship has influenced numerous emerging scholars in cardiovascular medicine, many of whom have gone on to successful academic and clinical careers. His guidance combines a rigorous scientific approach with a deep sense of responsibility to patient care and scientific integrity, shaping a legacy that extends well beyond his own research output.

🔬 Future Contributions and Vision

Looking ahead, Dr. Cheng remains committed to the advancement of cardiovascular research, with a continued focus on uncovering the cellular and mechanical determinants of heart disease. His vision includes fostering collaborative projects that integrate biomedical engineering, imaging, and computational modeling to further understand cardiac performance. With decades of experience and a forward-thinking approach, Dr. Cheng’s future contributions are poised to leave a lasting mark on the field of translational cardiovascular medicine.

Publication

  1. Title: Increased CaMKII activation and contrast changes of cardiac β1-and β3-Adrenergic signaling pathways in a humanized angiotensinogen model of hypertension
    Authors: Sun, Xiaoqiang; Cao, Jing; Chen, Zhe; Ferrario, Carlos M.; Cheng, Cheping
    Year: 2023
    Journal: Heliyon

 

  1. Title: Calmodulin-dependent protein kinase II activation promotes kidney mesangial expansion in streptozotocin-induced diabetic mice
    Authors: Mikhailov, Alexei V.; Liu, Yixi; Cheng, Hengjie; Lin, Jen Jar; Cheng, Cheping
    Year: 2022
    Journal: Heliyon

 

  1. Title: Chronic GPR30 agonist therapy causes restoration of normal cardiac functional performance in a male mouse model of progressive heart failure: Insights into cellular mechanisms
    Authors: Zhang, Xiaowei; Li, Tiankai; Cheng, Hengjie; Groban, Leanne; Cheng, Cheping
    Year: 2021
    Journal: Life Sciences

 

  1. Title: Chronic Ca2+/calmodulin-dependent protein Kinase II inhibition rescues advanced heart failure
    Authors: Liu, Yixi; Shao, Qun; Cheng, Hengjie; Zhao, David Xiao Ming; Cheng, Cheping
    Year: 2021
    Journal: Journal of Pharmacology and Experimental Therapeutics

 

  1. Title: The Angiotensin-(1–12)/Chymase axis as an alternate component of the tissue renin angiotensin system
    Authors: Ferrario, Carlos M.; Groban, Leanne; Wang, Hao; Sun, Xuming; Ahmad, Sarfaraz
    Year: 2021
    Journal: Molecular and Cellular Endocrinology

 

  1. Title: Reversal of angiotensin-(1–12)-caused positive modulation on left ventricular contractile performance in heart failure: Assessment by pressure-volume analysis
    Authors: Li, Tiankai; Zhang, Zhi; Zhang, Xiaowei; Ferrario, Carlos M.; Cheng, Cheping
    Year: 2020
    Journal: International Journal of Cardiology

 

  1. Title: Female Heart Health: Is GPER the Missing Link?
    Authors: Groban, Leanne; Tran, Q. K.; Ferrario, Carlos M.; Wang, Hao; Lindsey, Sarah H.
    Year: (Not specified, but likely 2020 or 2021)
    Journal: (Not specified)

 

🏁 Conclusion

Dr. Cheng’s legacy is one of intellectual rigor, clinical relevance, and mentorship. His work has not only deepened the scientific understanding of cardiac physiology but has also shaped modern approaches to diagnosing and managing heart failure. With a career spanning continents and disciplines, Dr. Cheng continues to be a guiding force in cardiovascular medicine, and his future contributions are anticipated to further advance the frontiers of heart research and patient care.

 

Mustafa Nazıroğlu | Cellular Neuroscience | Neuroscience Research Excellence Award

Published on by Neuroscientists

Prof. Mustafa Nazıroğlu | Cellular Neuroscience | Neuroscience Research Excellence Award

Prof. Mustafa Nazıroğlu,  Suleyman Demirel University, Turkey.

Professor Mustafa Nazıroğlu is a distinguished scholar with dual doctorates in Physiology and Neuroscience. Beginning his academic journey at Fırat University and advancing to leadership roles at Süleyman Demirel University, he has become a global authority in the fields of oxidative stress, calcium signaling, and TRP ion channels. His research portfolio includes over 270 peer-reviewed articles and thousands of citations, showcasing a profound impact on cellular neuroscience. Beyond research, he has led major international congresses, served on editorial boards of top journals, and has been honored with numerous awards and fellowships in Europe, Asia, and North America.

Profile

Orcid

 

🎓 Early Academic Pursuits

Professor Mustafa Nazıroğlu embarked on his academic journey with a degree from the Faculty of Veterinary Medicine at Fırat University in 1991. Driven by a profound curiosity for physiological mechanisms, he pursued a Ph.D. in Physiology at the same institution, which he completed between 1992 and 1996. His academic ambitions later led him to earn a second Ph.D. in Neuroscience from Süleyman Demirel University (SDU) in 2018, reflecting his commitment to interdisciplinary scholarship and continuous learning.

🧠 Professional Endeavors in Neuroscience and Biophysics

Currently, Professor Nazıroğlu holds the position of Head of the Department of Biophysics and Neuroscience at SDU Medical Faculty. His professional path has been shaped by a deep dedication to academic leadership, having served in several key roles including department head, director of the Neuroscience Research Centre (NOROBAM), and chair of numerous international scientific congresses. Notably, he has successfully organized the biennial International World Congress of Oxidative Stress, Calcium Signalling and TRP Channels from 2006 to 2020, as well as the International Brain Research School series from 2015 to 2024. His influence has also reached global platforms, including service on the organizing committee for the TEMA-14 Congress in Hubei, China, in 2011.

🔬 Contributions and Research Focus

A prolific researcher, Professor Nazıroğlu has significantly advanced our understanding of oxidative stress, calcium signaling, apoptosis, and ion channel (TRP) physiology. His scientific output includes 274 international research articles, 19 review papers, and six book chapters, collectively amassing over 11,500 citations and earning him a Scopus h-index of 59. He has also contributed as an editorial and reviewing member for leading journals such as Biological Trace Element Research, Scientific Reports (Nature Publishing), Frontiers in Physiology, and Current Neuropharmacology, among others. His research has bridged cellular neuroscience with therapeutic strategies, making him a vital contributor to the global scientific discourse.

🏅 Accolades and Recognition

Throughout his career, Professor Nazıroğlu has received numerous national and international honors, celebrating his scientific achievements and global engagement. These include the NATO Research Fellowship (Germany), the Alexander von Humboldt Fellowship (Germany), and the Young Investigative Scientist Award (USA). He has also been recognized by the Turkish Scientific and Technological Research Council (TÜBİTAK), the Howard Hughes Medical Institute (USA), and was the recipient of the prestigious Khwarizmi International Award (Iran). His visiting professorships at institutions in the UK, Qatar, and Japan further underscore his international reputation and collaboration.

🌍 Impact and Influence

Professor Nazıroğlu’s impact extends beyond academic publishing and conference organization. As a mentor, speaker, and panel member, he has shaped the careers of young neuroscientists and fostered a collaborative global network of researchers in calcium signaling and oxidative biology. His participation in expert advisory boards and scientific panels illustrates the depth of his influence on both research policy and biomedical innovation.

📘 Legacy of Knowledge

With over three decades dedicated to science and education, Professor Nazıroğlu has built a lasting legacy grounded in scientific rigor and visionary leadership. His conferences and educational programs, especially the International Brain Research School, have become cornerstone events for knowledge exchange in neuroscience. He has laid a strong foundation for future advancements in TRP channel research and neurophysiology.

🚀 Future Contributions and Vision

Looking forward, Professor Nazıroğlu continues to guide critical research on cellular responses to oxidative stress and ion channel modulation. His forward-thinking approach, combined with an inclusive scientific philosophy, ensures that he remains a leading voice in shaping the next era of biomedical research. With ongoing collaborative projects and mentorship of emerging scholars, his work is poised to influence both clinical and theoretical frontiers for years to come.

Publication

 

  • Title: Vitamin D Supplementation Modulates Blood and Tissue Zinc, Liver Glutathione and Blood Biochemical Parameters in Diabetic Rats on a Zinc-Deficient Diet
    Authors: Kechrid, Z.; Hamdiken, M.; Nazıroğlu, M.; Flores-Arce, M.
    Year: 2023

 

  • Title: Low molecular weight heparin treatment reduced apoptosis and oxidative cytotoxicity in the thrombocytes of patients with recurrent pregnancy loss and thrombophilia: Involvements of TRPM2 and TRPV1 channels
    Authors: Dal, Y.; Nazıroğlu, M.; Özkaya, M.O.
    Year: 2023

 

  • Title: NMDA Receptor Activation Stimulates Hypoxia-Induced TRPM2 Channel Activation, Mitochondrial Oxidative Stress, and Apoptosis in Neuronal Cell Line: Modular Role of Memantine
    Authors: Kenan Yıldızhan; Mustafa Nazıroğlu
    Year: 2023

 

  • Title: Honey bee venom melittin increases the oxidant activity of cisplatin and kills human glioblastoma cells by stimulating the TRPM2 channel
    Authors: Kemal Ertilav; Mustafa Nazıroğlu
    Year: 2023

 

  • Title: Silver nanoparticles potentiate antitumor and oxidant actions of cisplatin via the stimulation of TRPM2 channel in glioblastoma tumor cells
    Authors: Yener Akyuva; Mustafa Nazıroğlu
    Year: 2023

 

  • Title: A novel antagonist of TRPM2 and TRPV4 channels: Carvacrol
    Author: Nazıroğlu, M.
    Year: 2022

 

  • Title: Amantadine Attenuated Hypoxia-Induced Mitochondrial Oxidative Neurotoxicity, Apoptosis, and Inflammation via the Inhibition of TRPM2 and TRPV4 Channels
    Authors: Öcal, Ö.; Coşar, A.; Nazıroğlu, M.
    Year: 2022

 

  • Title: Eicosapentaenoic acid enhanced apoptotic and oxidant effects of cisplatin via activation of TRPM2 channel in brain tumor cells
    Authors: Öcal, Ö.; Nazıroğlu, M.
    Year: 2022

 

  • Title: Paclitaxel Promotes Oxidative Stress–Mediated Human Laryngeal Squamous Tumor Cell Death through the Stimulation of Calcium and Zinc Signaling Pathways: No Synergic Action of Melatonin
    Authors: Kumbul, Y.Ç.; Nazıroğlu, M.
    Year: 2022

 

  • Title: Protective role of selenium on MPP⁺ and homocysteine-induced TRPM2 channel activation in SH-SY5Y cells
    Authors: Yıldızhan, K.; Nazıroğlu, M.
    Year: 2022

 

🧾 Conclusion

Through an outstanding blend of academic excellence, innovative research, and global collaboration, Professor Nazıroğlu has carved a legacy as a leading figure in neuroscience and biophysics. His efforts in organizing international platforms and mentoring young scientists reflect a career committed to advancing knowledge and fostering global scientific networks. With continued contributions and visionary leadership, he remains a driving force in shaping the future of cellular neurophysiology and therapeutic discovery.

Clotilde Guidetti | Neuropharmacology | Best Researcher Award

Published on by Neuroscientists

Dr. Clotilde Guidetti | Neuropharmacology | Best Researcher Award

Dr. Clotilde Guidetti, Harvard Medical School, Massachusetts General Hospital, United States.

Clotilde Guidetti is an accomplished early-career physician-scientist specializing in Child and Adolescent Neuropsychiatry. With a classical foundation and medical training from the University of Genoa, she excelled academically, earning multiple merit awards and graduating Summa Cum Laude. She completed her specialized residency at the Catholic University of Rome, further refining her clinical expertise. Clotilde’s research focus lies in neurodevelopmental disorders, behavioral interventions, and psychopharmacology in pediatric populations. She has already demonstrated promise as an independent researcher through competitive grant submissions and award-winning conference presentations. Based in Boston, she is actively shaping a career that bridges clinical care and scientific innovation.

Profile

Scopus

 

🎓 Early Academic Pursuits

Clotilde Guidetti began her academic journey with a deep-rooted passion for understanding the human mind and behavior. She earned her High School Diploma in Classical Studies from the prestigious State High School Andrea D’Oria, an early indication of her strong intellectual curiosity and dedication to learning. This foundation in classical education provided her with a broad humanistic perspective that continues to inform her clinical and research approach. She then pursued her Medical Degree at the University of Genoa, where she graduated Summa Cum Laude in 2020. Her academic record was consistently marked by distinction, earning multiple Academic Merit Awards for clinical excellence during her medical studies.

🧠 Professional Endeavors

Following her graduation, Dr. Guidetti further specialized in the field of Child and Adolescent Neuropsychiatry through a rigorous residency program at the Catholic University of Rome. Completed in November 2024, her residency was also distinguished with Summa Cum Laude honors, reflecting both her clinical acumen and compassionate engagement with young patients. Her professional training combined intensive clinical work with scholarly research, preparing her to address complex neurodevelopmental and psychiatric disorders in children and adolescents.

🔬 Contributions and Research Focus

Dr. Guidetti’s primary research interests lie at the intersection of neurodevelopment, behavioral disorders, and psychopharmacology in pediatric populations. Her clinical insights are deeply enriched by her scientific inquiries, particularly those focused on the early diagnosis and personalized treatment of neuropsychiatric conditions. She has already begun shaping her independent research path, as seen in her recent submission for the Brain & Behavior Research Foundation Young Investigator Grant in January 2025. Her project, currently under review, reflects her growing reputation as an emerging scholar in the domain of pediatric neuropsychiatry.

🏅 Accolades and Recognition

Throughout her academic and clinical journey, Clotilde Guidetti has been the recipient of multiple honors that highlight her outstanding abilities. These include three Academic Merit Awards from the University of Genoa and a prestigious Erasmus Socrates Fellowship in 2017–2018, which broadened her training in an international context. In 2022, she received the Attilio Sabato Award from the Società Italiana di Neuropsicofarmacologia (SINPF) for the best poster presentation—an achievement that not only celebrated her communication skills but also her innovative scientific thinking in neuropsychopharmacology.

🌍 Impact and Influence

Though early in her career, Dr. Guidetti has already begun to leave a meaningful mark on the field of child and adolescent mental health. Her dual focus on clinical excellence and academic inquiry ensures that her work resonates both within medical communities and in the lives of the families she serves. With a practice grounded in empathy and scientific rigor, she exemplifies the new generation of clinician-scientists committed to transforming mental health care for the most vulnerable populations.

🧬 Legacy and Future Contributions

As she looks to the future, Clotilde Guidetti aims to expand her contributions to academic psychiatry through collaborative research, cross-disciplinary studies, and the mentorship of emerging professionals in the field. Her continued involvement in national and international research networks promises to amplify her influence, paving the way for innovative treatments and holistic models of care in pediatric neuropsychiatry. Her vision is firmly centered on early intervention, neurodevelopmental resilience, and the integration of clinical practice with cutting-edge neuroscience.

📚 Academic Footprint

Dr. Guidetti currently resides and practices in Boston, Massachusetts, where she continues to build her clinical and research profile. Her dual base—rooted in Italy and expanding into the United States—places her at the nexus of transatlantic collaboration. With each project and presentation, she further refines her expertise and extends her academic footprint, fostering a dynamic career defined by global engagement, intellectual integrity, and unwavering commitment to child and adolescent mental health.

Publication

  • Title: Antidepressants in the acute treatment of post-traumatic stress disorder in adults: a systematic review and meta-analysis

  • Authors: Guidetti, Clotilde; Feeney, Anna; Hock, Rebecca S.; Fava, Maurizio; Papakostas, George I.

  • Year: 2024

 

📝 Conclusion

Dr. Guidetti embodies the ideal of a compassionate clinician and rigorous academic, poised to make significant contributions to the future of child and adolescent mental health. Her career so far reflects a seamless blend of scholarly excellence, clinical sensitivity, and a drive to push the boundaries of understanding in neuropsychiatry. As she continues to expand her research and collaborative efforts globally, her work promises to influence both scientific discourse and practical approaches in mental health care—building a legacy rooted in evidence, empathy, and innovation.

 

Handrean Soran | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Handrean Soran | Clinical Neuroscience | Best Researcher Award

Prof. Handrean Soran,  Manchester University NHS Foundation Trust, United Kingdom.

Dr. Handrean Soran is a distinguished British endocrinologist and researcher with expertise in diabetes, endocrinology, and cardiovascular diseases. His academic journey began in Iraq and advanced through the UK, where he earned prestigious medical qualifications, including an MD in Medicine and MSc in Diabetes and Endocrinology. Throughout his career, Dr. Soran has contributed significantly to research on the relationship between diabetes and cardiovascular health, publishing extensively in high-impact journals like The New England Journal of Medicine and Lancet. His work has garnered global recognition, including an H-index of 49 and numerous accolades, solidifying his position as a leader in his field.

Profile

Google Scholar

 

Early Academic Pursuits 📚

Handrean Soran’s academic journey began in the Kurdistan region of Iraq, where he completed his A-levels with an impressive score of 94.5% from Sulemani High School in 1985. His drive for knowledge led him to pursue his MBChB at Al-Mustansyria University in Baghdad, Iraq, graduating in 1990. This foundational education set the stage for a career dedicated to medical research and practice. After completing his medical degree, he pursued further specialized training in the UK, where he earned his MRCP from the Royal College of Physicians in Edinburgh in 1999, and later, an MSc in Diabetes and Endocrinology from the University of Liverpool in 2006. These early academic milestones laid the foundation for his later expertise in endocrinology and diabetes, fields that would define his career.

Professional Endeavors 🏥

Dr. Handrean Soran’s professional journey is marked by a dedication to medicine, particularly in the fields of endocrinology and diabetes. He has held significant roles in prestigious institutions, with his current position in the Department of Diabetes, Endocrinology, and Metabolism at Manchester University Hospitals NHS Foundation Trust. His medical career was further enhanced by his qualifications as a Fellow of the Royal College of Physicians (FRCP) from both Glasgow and Edinburgh. Throughout his career, Dr. Soran has worked on developing innovative approaches in clinical care and research, constantly striving to improve patient outcomes and advancing medical knowledge.

Contributions and Research Focus 🔬

Dr. Soran’s research focus primarily centers on diabetes, endocrinology, and cardiovascular health, specifically the interplay between metabolic disorders and heart disease. His research efforts have been integral to understanding the link between diabetes and cardiovascular risk, with a significant body of work examining the effects of treatments on these interconnected conditions. His contributions have been recognized through multiple high-impact publications in renowned journals such as the New England Journal of Medicine, Lancet, and European Heart Journal. With an H-index of 49 and over 130 citations, Dr. Soran’s work continues to shape the clinical landscape in these areas, driving further advancements in treatment protocols and therapeutic strategies for diabetes and cardiovascular diseases.

Accolades and Recognition 🏆

Dr. Soran’s career has been decorated with numerous accolades, affirming his status as a leader in his field. He achieved the prestigious title of Fellow of the Royal College of Physicians (FRCP) in both Edinburgh and Glasgow, a testament to his clinical expertise and contribution to medical science. His groundbreaking work in diabetes and cardiovascular research has earned him recognition not only from peers but also from major medical institutions. His publications in top-tier journals further highlight his academic prowess, solidifying his position as a key thought leader in the medical and academic communities.

Impact and Influence 🌍

Dr. Handrean Soran’s work extends beyond the realm of research publications; it has made a lasting impact on the clinical management of diabetes and cardiovascular diseases worldwide. His insights have contributed to shaping healthcare policies and clinical practices, particularly in the management of diabetic patients at high cardiovascular risk. Through his collaboration with the Division of Cardiovascular Sciences at the University of Manchester, he has fostered interdisciplinary approaches to solving complex medical challenges, advancing the integration of cardiovascular care with endocrinology. His work has influenced not only academic circles but also clinical practice, providing new directions for patient care.

Legacy and Future Contributions 🌱

As Dr. Soran continues his impactful work, his legacy is one of dedication to improving patient health outcomes and advancing the fields of endocrinology and diabetes. With a deep commitment to teaching and mentorship, Dr. Soran plays a pivotal role in training the next generation of doctors and researchers. His future contributions are poised to further explore the intricate relationship between metabolic disorders and cardiovascular health, addressing the growing global burden of these interconnected diseases. His work will undoubtedly continue to guide both clinical practice and future research in endocrinology, diabetes, and cardiovascular medicine, ensuring his ongoing influence in these critical areas.

Global Recognition and Influence 🌐

Dr. Soran’s influence reaches across borders, as evidenced by his extensive publication record and recognition within the global medical community. His research has not only enriched the scientific literature but also contributed to global health initiatives, particularly in the area of metabolic disorders and cardiovascular diseases. With collaborations spanning multiple continents, Dr. Soran is dedicated to improving health outcomes globally, offering expert insights into the prevention and management of diabetes and heart disease. His role in shaping clinical guidelines and his participation in international research collaborations further amplify his global impact.

Academic and Professional Leadership 🎓

In addition to his research contributions, Dr. Soran’s leadership within academia is profound. He holds multiple academic positions, including his affiliation with the University of Manchester, where he plays an integral role in advancing research within the Division of Cardiovascular Sciences. His leadership extends to mentoring young researchers and clinicians, helping to foster a new generation of experts in endocrinology and diabetes. Dr. Soran’s academic vision continues to drive progress in both education and research, making significant strides in improving how diabetes and cardiovascular diseases are understood and treated. His future work promises to leave a lasting mark on medical education and the advancement of scientific knowledge.

Publication

  • Cardiovascular efficacy and safety of bococizumab in high-risk patients
    Author: PM Ridker
    Year: 2017

 

  • Volanesorsen and triglyceride levels in familial chylomicronemia syndrome
    Author: JL Witztum
    Year: 2019

 

  • Triglyceride lowering with pemafibrate to reduce cardiovascular risk
    Author: A Das Pradhan
    Year: 2022

 

  • Diabetes dyslipidemia
    Author: JD Schofield
    Year: 2016

 

  • Lysosomal acid lipase deficiency–an under-recognized cause of dyslipidaemia and liver dysfunction
    Author: Ž Reiner
    Year: 2014

 

  • Obesity: a critical risk factor in the COVID‐19 pandemic
    Author: S Kwok
    Year: 2020

 

  • Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY …
    Author: KK Ray
    Year: 2019

 

  • Hypercholesterolaemia and its management
    Author: D Bhatnagar
    Year: 2008

 

  • Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
    Author: B Williams
    Year: 2018

 

  • Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset …
    Author: FJ Raal
    Year: 2017

 

Conclusion

Dr. Handrean Soran’s career is marked by profound contributions to medical science, particularly in the fields of diabetes and cardiovascular health. His groundbreaking research and clinical expertise have had a significant impact on both academic and healthcare practices worldwide. As a recognized leader in his field, Dr. Soran’s work continues to influence the management of metabolic and cardiovascular diseases, and his future contributions promise to further advance these critical areas of medical research and practice. His legacy is one of dedication, leadership, and a commitment to improving health outcomes globally.